Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 544

1.

Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.

Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J, Bosl GJ, Motzer RJ.

J Clin Oncol. 2005 Sep 20;23(27):6549-55.

PMID:
16170162
2.

Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study.

Mardiak J, Sálek T, Sycová-Milá Z, Obertová J, Hlavatá Z, Mego M, Recková M, Koza I.

Neoplasma. 2005;52(6):497-501.

PMID:
16284696
3.

Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy.

Ronnen EA, Kondagunta GV, Bacik J, Marion S, Bajorin DF, Sheinfeld J, Bosl GJ, Motzer RJ.

J Clin Oncol. 2005 Oct 1;23(28):6999-7004.

PMID:
16192587
4.

Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors.

Park S, Lee S, Lee J, Park SH, Park JO, Kang WK, Park YS, Lim HY.

Onkologie. 2011;34(8-9):416-20. doi: 10.1159/000331129. Epub 2011 Aug 23.

PMID:
21934340
5.

Paclitaxel in salvage therapy for germ cell tumors.

Motzer RJ.

Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-83-S15-85.

PMID:
9346229
6.

Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer.

Motzer RJ, Sheinfeld J, Mazumdar M, Bains M, Mariani T, Bacik J, Bajorin D, Bosl GJ.

J Clin Oncol. 2000 Jun;18(12):2413-8.

PMID:
10856101
7.

Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors.

Bokemeyer C.

Oncology. 1998 May-Jun;55(3):177-88. Review.

PMID:
9560052
8.

The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.

Bokemeyer C, Harstrick A, Beyer J, Metzner B, Rüther U, Hartmann JT, Holstein K, Derigs HG, de Wit R, Casper J, Schöffski P, Kührer I, Illiger HJ, Kempf B, Reichle A, Föller A, Hossfeld DK, Fischer JT, Berdel WE, Gerhartz HH, Kirchner H, Pflüger KH, Ostermann H, Kanz L, Schmoll HJ.

Semin Oncol. 1998 Apr;25(2 Suppl 4):24-32; discussion 45-8. Review.

PMID:
9578059
9.

Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.

Hartmann JT, Gauler T, Metzner B, Gerl A, Casper J, Rick O, Horger M, Schleicher J, Derigs G, Mayer-Steinacker R, Beyer J, Kuczyk MA, Bokemeyer C; German Testicular Cancer Study Group..

J Clin Oncol. 2007 Dec 20;25(36):5742-7.

PMID:
18089869
10.

Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients.

Soulié P, Garrino C, Bensmaïne MA, Bekradda M, Brain E, Di Palma M, Goupil A, Misset JL, Cvitkovic E.

J Cancer Res Clin Oncol. 1999 Dec;125(12):707-11.

PMID:
10592105
11.
12.
13.

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours.

Fosså SD, Stenning SP, Gerl A, Horwich A, Clark PI, Wilkinson PM, Jones WG, Williams MV, Oliver RT, Newlands ES, Mead GM, Cullen MH, Kaye SB, Rustin GJ, Cook PA.

Br J Cancer. 1999 Jul;80(9):1392-9.

14.

Paclitaxel (Taxol) combination therapy for resistant germ cell tumors.

Motzer RJ.

Semin Oncol. 2000 Feb;27(1 Suppl 1):33-5. Review.

PMID:
10697042
15.

Importance of surgery as salvage treatment after high dose chemotherapy failure in germ cell tumors.

Fléchon A, Rivoire M, Biron P, Droz JP.

J Urol. 2001 Jun;165(6 Pt 1):1920-6.

PMID:
11371882
16.

Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol.

Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL.

J Clin Oncol. 2004 Mar 1;22(5):846-53.

PMID:
14990640
17.
18.

The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors.

Motzer RJ, Cooper K, Geller NL, Bajorin DF, Dmitrovsky E, Herr H, Morse M, Fair W, Sogani P, Russo P, et al.

Cancer. 1990 Dec 15;66(12):2476-81.

19.

Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors.

Kondagunta GV, Bacik J, Sheinfeld J, Bajorin D, Bains M, Reich L, Deluca J, Budnick A, Ishill N, Mazumdar M, Bosl GJ, Motzer RJ.

J Clin Oncol. 2007 Jan 1;25(1):85-90. Erratum in: J Clin Oncol. 2007 May 20;25(15):2149.

PMID:
17194908
20.

Paclitaxel and cisplatin as salvage treatment in patients with non-seminomatous germ cell tumour who failed to achieve a complete remission on induction chemotherapy.

Tjulandin SA, Titov DA, Breder VV, Sidorova NJ, Popov AJ, Kupchan DZ, Garin AM.

Clin Oncol (R Coll Radiol). 1998;10(5):297-300.

PMID:
9848329

Supplemental Content

Support Center